12:00 AM
Mar 05, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Actelion preclinical data

Researchers at Wayne State University School of Medicine reported data from rats showing that IV clazosentan administered 2 and 24 hours after TBI reduced the extent of injury-induced hypoperfusion as measured by arterial spin labeling MRI and improved...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >